loading
Allarity Therapeutics Inc stock is traded at $1.4582, with a volume of 247.07K. It is up +0.69% in the last 24 hours and down -1.02% over the past month. Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$1.445
Open:
$1.41
24h Volume:
247.07K
Relative Volume:
0.04
Market Cap:
$21.27M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00708
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
-9.63%
1M Performance:
-1.02%
6M Performance:
+54.79%
1Y Performance:
-14.91%
1-Day Range:
Value
$1.40
$1.47
1-Week Range:
Value
$1.40
$1.77
52-Week Range:
Value
$0.6138
$2.35

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Name
Name
Allarity Therapeutics Inc
Name
Phone
401-426-4664
Name
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Name
Employee
7
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ALLR's Discussions on Twitter

Compare ALLR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ALLR
Allarity Therapeutics Inc
1.455 20.99M 0 -11.90M -12.75M -206.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
418.97 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
489.73 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.38 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
845.47 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.54 34.49B 398.11M -1.03B -868.57M -5.7032

Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-28-25 Initiated Ascendiant Capital Markets Buy

Allarity Therapeutics Inc Stock (ALLR) Latest News

pulisher
09:22 AM

How Allarity Therapeutics Inc. stock performs in weak economyJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com

09:22 AM
pulisher
Oct 16, 2025

Is it too late to sell Allarity Therapeutics Inc.2025 Volatility Report & Daily Profit Maximizing Tips - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Real time social sentiment graph for Allarity Therapeutics Inc.Rate Cut & High Conviction Buy Zone Picks - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

How to build a custom watchlist for Allarity Therapeutics Inc.July 2025 Earnings & Daily Stock Trend Reports - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Using data filters to optimize entry into Allarity Therapeutics Inc.July 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Real time pattern detection on Allarity Therapeutics Inc. stockAnalyst Downgrade & Risk Managed Investment Signals - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Intraday pattern recognizer results for Allarity Therapeutics Inc.Portfolio Performance Summary & Fast Moving Stock Trade Plans - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Allarity Therapeutics registers 1.56M shares for resale - MSN

Oct 13, 2025
pulisher
Oct 12, 2025

Published on: 2025-10-12 09:54:11 - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Published on: 2025-10-12 02:57:16 - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Is Allarity Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is it time to cut losses on Allarity Therapeutics Inc.Quarterly Profit Review & Long Hold Capital Preservation Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Live market analysis of Allarity Therapeutics Inc.Wall Street Watch & Long-Term Investment Growth Plans - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Is Allarity Therapeutics Inc. stock a smart buy before Fed meetingAnalyst Downgrade & Expert Curated Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can technical indicators confirm Allarity Therapeutics Inc.’s reversalIndex Update & Free Growth Oriented Trading Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using data tools to time your Allarity Therapeutics Inc. exitQuarterly Trade Summary & Intraday High Probability Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

What drives Allarity Therapeutics Inc stock priceMid Cap Growth Trends & Access Free Risk Analysis Before You Invest - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

Is a relief rally coming for Allarity Therapeutics Inc. holdersEarnings Beat & Technical Buy Zone Confirmation - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

What Wall Street predicts for Allarity Therapeutics Inc. stock priceJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What MACD and RSI say about Allarity Therapeutics Inc.2025 Dividend Review & Weekly Market Pulse Updates - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

Allarity Therapeutics, Inc. (NASDAQ:ALLR) Sees Large Decrease in Short Interest - Defense World

Oct 01, 2025

Allarity Therapeutics Inc Stock (ALLR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.02
price up icon 1.89%
$87.92
price up icon 0.69%
$33.13
price up icon 1.13%
$105.46
price up icon 0.34%
biotechnology ONC
$315.77
price down icon 0.61%
$165.71
price up icon 1.49%
Cap:     |  Volume (24h):